Whanin Pharm Co Ltd 016580
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- KRW 14,420.00
- Day Range
- KRW 14,360.00–14,490.00
- 52-Week Range
- KRW 12,410.00–16,280.00
- Bid/Ask
- KRW 14,360.00 / KRW 14,400.00
- Market Cap
- KRW 219.24 Bil
- Volume/Avg
- 4,137 / 20,109
Key Statistics
- Price/Earnings (Normalized)
- 7.39
- Price/Sales
- 0.96
- Dividend Yield (Trailing)
- 2.09%
- Dividend Yield (Forward)
- 2.09%
- Total Yield
- 2.09%
Company Profile
Whanin Pharm Co Ltd is a pharmaceutical company. The company develops, manufactures, markets, and sells the therapeutic products. It offers antibiotics, cardiovascular drugs, CNS stimulants, gastrointestinal drugs, multivitamins and other products. The company’s products include Antiasthmatics; Antidepressants; Antipsychotics; Anxiolytics and hypnotics; and Antiepileptics.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 653
- Website
- http://www.whanin.co.kr
Comparables
Valuation
|
Metric
|
016580
|
140410
|
271980
|
|---|---|---|---|
Price/Earnings (Normalized) | 7.39 | — | 38.32 |
Price/Book Value | 0.61 | 21.22 | 1.60 |
Price/Sales | 0.96 | 32.90 | 0.35 |
Price/Cash Flow | 5.64 | — | 16.18 |
Price/Earnings
016580
140410
271980
Financial Strength
|
Metric
|
016580
|
140410
|
271980
|
|---|---|---|---|
Quick Ratio | 3.93 | 2.17 | 0.63 |
Current Ratio | 5.30 | 2.51 | 1.00 |
Interest Coverage | 1,345.19 | −43.24 | 1.15 |
Quick Ratio
016580
140410
271980
Profitability
|
Metric
|
016580
|
140410
|
271980
|
|---|---|---|---|
Return on Assets (Normalized) | 7.92% | −17.65% | 1.45% |
Return on Equity (Normalized) | 8.87% | −33.91% | 4.28% |
Return on Invested Capital (Normalized) | 7.89% | −28.13% | 4.70% |
Return on Assets
016580
140410
271980
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Dhsmbpqh | Srzcs | $77.1 Bil | |
MKKGY
| Merck KGaA ADR | Csvmfszw | Vwdwwg | $72.9 Bil | |
HLN
| Haleon PLC ADR | Ghpklwx | Vyjwg | $37.5 Bil | |
VTRS
| Viatris Inc | Jzvgwfkxl | Vvld | $13.3 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Qlhcctgk | Zjhws | $11.7 Bil | |
CTLT
| Catalent Inc | Xkjntjw | Ydktv | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Vzdnjpl | Mhrg | $4.2 Bil | |
CURLF
| Curaleaf Holdings Inc | Jvjmhpsl | Vgbr | $4.0 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Cysbfdzz | Yjmnmm | $3.5 Bil | |
GTBIF
| Green Thumb Industries Inc | Xfyjndrms | Cdt | $3.0 Bil |